The Possible Interaction between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and its Ligand on Dermal Macrophages

Journal of Investigative Dermatology

Volumn 135, Issue 10, 2015, Pages 2547-2550

  Kambayashi, Yumi ^a   Fujimura, Taku ^a   Furudate, Sadanori ^a   Asano, Masayuki ^a   Kakizaki, Aya ^a   Aiba, Setsuya ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRILYSIN; OSTEOCLAST DIFFERENTIATION FACTOR; MESSENGER RNA; TUMOR MARKER;

APOCRINE GLAND; BREAST CANCER; BREAST EPITHELIUM CELL; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; EPIDERMIS; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LASER CAPTURE MICRODISSECTION; LETTER; MACROPHAGE; PAGET SKIN DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; TUMOR MICROENVIRONMENT; CELL COMMUNICATION; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE;

BIOMARKERS, TUMOR; BIOPSY, NEEDLE; CELL COMMUNICATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MACROPHAGES; MATRIX METALLOPROTEINASE 7; NF-KAPPA B; PAGET DISEASE, EXTRAMAMMARY; RANK LIGAND; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY;

EID: 84941414611     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.199     Document Type: Letter

References (12)

1. Ackerman AB, Kessler G, Gyorfi T et al. (2007) Contrary view: the breast is not an organ per se, but a distinctive region of skin and subcutaneous tissue. Am J Dermatopathol 29: 211-8
2. Bates GJ, Fox SB, Han C et al. (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24: 5373-80
3. Bhatia P, Sanders MM, Hansen MF (2005) Expression of receptor activator of nuclear factor-kappaB is inversely correlated with metastatic phenotype in breast carcinoma. Clin Cancer Res 11: 162-5
4. Fujimura T, Furudate S, Kambayashi Y et al. (2013) Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical Investigation. Clin Dev Immunol 2013: 164982
5. Fujimura T, Kambayashi Y, Hidaka T et al. (2012) Comparison of Foxp3+ regulatory T cells and CD163+ macrophages in invasive and non-invasive extramammary Paget's disease. Acta Derm Venereol 92: 625-8
6. Gonzalez-Suarez E (2011) RANKL inhibition: a promising novel strategy for breast cancer treatment. Clin Transl Oncol 13: 222-8
7. Hao NB, Lu MH, Fan YH et al. (2012) Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012: 948098
8. Loser K, Mehling A, Loeser S et al. (2006) Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 12: 1372-9
9. Lynch CC, Hikosaka A, Acuff HB et al. (2005) MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 7: 485-96
10. Medrek C, Ponten F, Jirstrom K et al. (2012) The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 12: 306
11. Press JZ, Allison KH, Garcia R et al. (2011) FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence. Gynecol Oncol 120: 296-9
12. Shiomi T, Noguchi T, Nakayama H et al. (2013) Clinicopathological study of invasive extramammary Paget's disease: subgroup comparison according to invasion depth. J Eur Acad Dermatol Venereol 27: 589-92